Market Place
Filter By Unselect All
Sub Category Unselect See All
Overview (18)
Country Unselect See All
Companies Unselect See All
Almelo Private (1)
AMRI (1)
Arevipharma GmbH (1)
CTX LIFESCIENCES (1)
Grace (1)
M2I Life (1)
Menadiona, S.L. (1)
Minakem SAS (1)
PCI Synthesis (1)
PMC Isochem (1)
Siegfried AG (1)
Selected Filter(s): Reset All
- Category Reset
- Sub Category Reset
- Country Reset
Halogenation Technology for Custom Manufacturing 
API Manufacturing >> Halogenation >> Overview
PMC Isochem offers halogenation technology for custom manufacturing and catalog products. Iodination, bromination and chorination are routinely run at large scale using various techniques and reagent.
Website
Halogenations and Other Hazardous Chemistries
API Manufacturing >> Halogenation >> Overview
AMRI's scientists have mastered the efficient production of APIs and intermediates using a broad range of hazardous chemistries.
Halogenation Reaction Capabilities
API Manufacturing >> Halogenation >> Overview
In addition to the classical chemical reactions, MINAKEM has developed a strong expertise in the field of halogenation at an industrial scale.
Bromination & Nitration Reactions
API Manufacturing >> Halogenation >> Overview
ScinoPharm's core competency will be to specialize in producing international cGMP-quality Active Pharmaceutical Ingredients through organic synthesis.
Bromination
API Manufacturing >> Halogenation >> Overview
Almelo has expertise in reaction chemistry.
Halogenation Reactions Capabilities
API Manufacturing >> Halogenation >> Overview
Menadiona is an independent privately owned company that has been involved in manufacturing active ingredients and key intermediates for the Pharmaceutical, Veterinary, Plant Health and Nutraceutical industries.
Fluorination Capabilities
API Manufacturing >> Halogenation >> Overview
Our fluorination capabilities include catalytic, non-catalytic, gas phase, and liquid phase fluorination using HF. Other specialised fluorination reactions include Balz- Schiemann, Schiemann and Swarts. Safe handlings of HF and Halogen exchange are our niche capabilities.
Technology Capabilities for Production of APIs
API Manufacturing >> Halogenation >> Overview
CTX Life Sciences has 83 reactors ranging from 0.1 m³ to 8.0 m³, with total reactor volume of 220 m³ and eight independent clean room areas. The supply of utilities and utility headers are isolated from manufacturing area to avoid congestion and cross contamination inside the plant.
Halogenation
API Manufacturing >> Halogenation >> Overview
Supriya Lifescience's contract manufacturing capabilities will encompass the capability to handle complex chemical reactions.
Halogenation Capabilities
API Manufacturing >> Halogenation >> Overview
Arevipharma offers three state-of-the-art, multi-purpose plants with a total reactor volume capacity of 150 m3, whichcomply with the cGMP standard and meet almost all customer requirements.